相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proteasome Inhibitor MG132 Induces BAG3 Expression Through Activation of Heat Shock Factor 1
Zhen-Xian Du et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Transcriptional upregulation of BAG3 upon proteasome inhibition
Hua-Qin Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Proteasome inhibition activates epidermal growth factor receptor (EGFR) and EGFR-independent mitogenic kinase signaling pathways in pancreatic cancer cells
Callum M. Sloss et al.
CLINICAL CANCER RESEARCH (2008)
Different induction of GRP78 and CHOP as a predictor of sensitivity to proteasome inhibitors in thyroid cancer cells
Hua-Qin Wang et al.
ENDOCRINOLOGY (2007)
Thymosinα1 stimulates cell proliferation by activating ERK1/2, JNK, and increasing cytokine secretion in human pancreatic cancer cells
Min Li et al.
CANCER LETTERS (2007)
Evidence for BAG3 modulation of HIV-1 gene transcription
Alessandra Rosati et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand
Gennaro Chiappetta et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Apoptosis inhibition in cancer cells: A novel molecular pathway that involves BAG3 protein
Alessandra Rosati et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer
Yue Y. Shi et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways
M Lauricella et al.
APOPTOSIS (2006)
Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
J Codony-Servat et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Arsenic trioxide induces Hsp70 expression via reactive oxygen species and JNK pathway in MDA231 cells
YH Kim et al.
LIFE SCIENCES (2005)
Proteasome inhibition as a novel therapeutic target in human cancer
SV Rajkumar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Proteasome inhibitor PS-341, induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling
Y Yang et al.
CANCER SCIENCE (2004)
Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role
GW Small et al.
MOLECULAR PHARMACOLOGY (2004)
p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells
T Hideshima et al.
ONCOGENE (2004)
Regulation by heavy metals and temperature of the human BAG-3 gene, a modulator of Hsp70 activity
MG Pagliuca et al.
FEBS LETTERS (2003)
BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis
MF Romano et al.
CELL DEATH AND DIFFERENTIATION (2003)
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
N Mitsiades et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosis
RZ Orlowski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines
Q Liao et al.
FEBS LETTERS (2001)
Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions
G Pearson et al.
ENDOCRINE REVIEWS (2001)
分享论文
